Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-20T02:42:13.798Z Has data issue: false hasContentIssue false

544 - Validation of a new cognitive screening tool, the Brain Health Test-7, for identification of mild cognitive impairment and early dementia in 3 differentkinds of hospital settings

Published online by Cambridge University Press:  01 November 2021

Meng-Shiuan Shie
Affiliation:
Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
Mei Xian Loi
Affiliation:
Department of Psychiatry, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
His-Chung Chen
Affiliation:
Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan. Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan.
Ming-Hsien Hsieh
Affiliation:
Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan. Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan.
Yi-Ting Lin
Affiliation:
Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan. Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chen-Chung Liu
Affiliation:
Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan. Department of Psychiatry, Hsin-Chu Branch, National Taiwan University, Taipei, Taiwan.
Pei-Ning Wang
Affiliation:
Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan. Aging and Health Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Jiahn-Jyh Chen
Affiliation:
Department of Geriatric Psychiatry, Taoyuan Psychiatric Center, Minitry of Health and Welfare, Taoyuan, Taiwan
Cheng-Sheng Chen
Affiliation:
Department of Psychiatry, Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan Department of Psychiatry, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chih-Cheng Hsu
Affiliation:
Division of Geriatrics and Gerontology, Institute of Population Health Sciences, National Health Research Institutes, Taiwan.
Tzung-Jeng Hwang
Affiliation:
Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan. Department of Psychiatry, College of Medicine, National Taiwan University, Taipei, Taiwan.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

The Brain Health Test-7 (BHT-7) is a revised tool from the original BHT, containing more tests about frontal lobe function. It was developed with theaim of identifying patients with mild cognitive impairment (MCI) and early dementia.

Research objective

Here we report the validity of the BHT-7 versus the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) in differentpsychiatry or neurology clinics.

Methods

Patients with memory complaints were recruited in this study from the outpatient clinic of psychiatry or neurology in 3 different kinds of hospitals. Allpatients underwent the evaluation of the BHT-7, MMSE, MoCA, and clinical dementia rating (CDR). The clinical diagnosis (normal, MCI, dementia) was made by consensus meeting, taking into account all available data.

Demographic data and the scores of the MMSE, MoCA, and BHT-7 between groups were compared. Logistic regression was adopted for analysis of optimal cutoff values, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), receiver operating characteristic (ROC) curve,and the area under the ROC curve (AUC).

Results

We enrolled a total of 1090 subjects (normal 402, MCI 317, dementia 371); of them, 705 (64.7%) were female. There was a statistically significant differencein age, years of education, and 3 cognitive test scores among the 3 groups.

Compared with the MMSE and MoCA, the BHT-7 performed slightly betterthan MMSE and MoCA in differentiating MCI or dementia from the normalcontrols (Table 1). For BHT- 7, the cutoff point was 17 between normal andMCI, and 14 between normal and dementia. These cutoff points for BHT-7were consistent through 3 different clinical settings, but inconsistent for MMSE and MoCA. The testing time for the BHT-7 was about 5-7 minutes, shorter than that of the MMSE and MoCA.

Conclusion

Compared with MMSE and MoCA, the BHT-7 showed slightly better performance in differentiating normal from MCI or dementia subjects. The testing time for the BHT-7 was shorter, and its cutoff points were consistent through different outpatient clinic settings. The results support that BHT-7 is auseful cognitive screening tool for MCI or early dementia in various hospital settings.

Table 1

Comparisons of the performance of BHT-7, MMSE, MoCA

AUCcutoffSENSPEPPVNPV
Normal vs. MCI
BHT-70.8532≦170.81700.74130.71350.8371
MMSE0.8061≦270.79500.68830.66840.8091
MoCA0.8316≦250.82020.67910.66840.8273
Normal vs. Dementia
BHT-70.9848≦140.94340.96020.95630.9484
MMSE0.9693≦240.88950.96260.95650.9040
MoCA0.9768≦210.92450.94280.93720.9312
Normal vs. MCI + Dementia
BHT-70.9241≦160.83720.84580.90280.7522
MMSE0.8941≦250.72820.91520.93650.6625
MoCA0.9099≦230.80810.85320.90410.7221

Type
OnDemand Poster
Copyright
© International Psychogeriatric Association 2021